# Bionano Genomics, Inc.: Form 8-K, filed Jun 5, 2026

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: 8-K
- Filed: 2026-06-05
- Accepted by EDGAR: Jun 5, 2026, 16:00 ET
- Period: 2026-06-02
- Accession: 0001411690-26-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000036/bngo-20260602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000036/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000141169026000036/bngo-20260602.htm

Filed Jun 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001411690-26-000036. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
